276 related articles for article (PubMed ID: 31300295)
21. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
22. Effect of lncRNA-BLACAT1 on drug resistance of non-small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression.
Ju ZS; Sun B; Bao D; Zhang XF
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9465-9472. PubMed ID: 33015788
[TBL] [Abstract][Full Text] [Related]
23. Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell Lung Cancer.
Fan H; Li J; Wang J; Hu Z
Med Sci Monit; 2019 Oct; 25():7624-7633. PubMed ID: 31601776
[TBL] [Abstract][Full Text] [Related]
24. lncRNA CCHE1 increased proliferation, metastasis and invasion of non-small lung cancer cells and predicted poor survival in non-small lung cancer patients.
Liao Y; Cheng S; Xiang J; Luo C
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1686-1692. PubMed ID: 29630113
[TBL] [Abstract][Full Text] [Related]
25. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
27. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
28. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
[TBL] [Abstract][Full Text] [Related]
29. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
[TBL] [Abstract][Full Text] [Related]
31. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
Wang L; Shang X; Feng Q
Cancer Biol Ther; 2019; 20(3):261-271. PubMed ID: 30481109
[TBL] [Abstract][Full Text] [Related]
32. Linc8087 predicts favorable prognosis and inhibits cell migration and invasion in NSCLC.
Qi Q; Chen C; Liu C; Zhang B; Ma Y; Zhang H; Huang W; Wang C
Pathol Res Pract; 2021 Sep; 225():153569. PubMed ID: 34391179
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer.
Qian B; Wang X; Mao C; Jiang Y; Shi Y; Chen L; Liu S; Wang B; Pan S; Tao Y; Shi H
Thorac Cancer; 2018 May; 9(5):589-597. PubMed ID: 29532622
[TBL] [Abstract][Full Text] [Related]
34. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
35. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA NEAT1 acts as oncogene in NSCLC by regulating the Wnt signaling pathway.
Sun SJ; Lin Q; Ma JX; Shi WW; Yang B; Li F
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):504-510. PubMed ID: 28239820
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
Jing H; Xia H; Qian M; Lv X
Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
[TBL] [Abstract][Full Text] [Related]
38. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis.
Qi L; Liu F; Zhang F; Zhang S; Lv L; Bi Y; Yu Y
Biomed Pharmacother; 2018 Jul; 103():1507-1515. PubMed ID: 29864936
[TBL] [Abstract][Full Text] [Related]
39. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.
Chen H; Zhang M; Zhang W; Li Y; Zhu J; Zhang X; Zhao L; Zhu S; Chen B
Thorac Cancer; 2018 Mar; 9(3):390-399. PubMed ID: 29341468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
